Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iBio (IBIO) Shares Outstanding (2016 - 2025)

iBio (IBIO) has disclosed Shares Outstanding for 15 consecutive years, with $30.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Shares Outstanding rose 227.79% to $30.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $30.1 million, a 227.79% increase, with the full-year FY2025 number at $19.3 million, up 124.36% from a year prior.
  • Shares Outstanding was $30.1 million for Q4 2025 at iBio, up from $20.3 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $218.2 million in Q1 2022 to a low of $1000.0 in Q2 2022.
  • A 5-year average of $29.6 million and a median of $8.7 million in 2021 define the central range for Shares Outstanding.
  • Biggest YoY gain for Shares Outstanding was 6045.11% in 2023; the steepest drop was 99.64% in 2023.
  • iBio's Shares Outstanding stood at $8.7 million in 2021, then tumbled by 92.91% to $618000.0 in 2022, then skyrocketed by 424.92% to $3.2 million in 2023, then soared by 182.61% to $9.2 million in 2024, then soared by 227.79% to $30.1 million in 2025.
  • Per Business Quant, the three most recent readings for IBIO's Shares Outstanding are $30.1 million (Q4 2025), $20.3 million (Q3 2025), and $19.3 million (Q2 2025).